Hostname: page-component-848d4c4894-mwx4w Total loading time: 0 Render date: 2024-06-24T22:42:31.941Z Has data issue: false hasContentIssue false
  • English
  • Français

Prevalence of Irritable Bowel Syndrome in Obsessive–Compulsive Disorder

Published online by Cambridge University Press:  07 November 2014

Prakash S. Masand ,
Nancy J. Keuthen ,
Sanjay Gupta ,
Subhdeep Virk ,
Barbara Yu-Siao  and
David Kaplan
Get access Rights & Permissions [Opens in a new window]

Abstract

Introduction:

Irritable bowel syndrome (IBS) occurs more frequently in psychiatric patients, especially those with anxiety and mood disorders.

Methods:

We sought to determine the prevalence and phenomenology of IBS in patients diagnosed with obsessive-compulsive disorder (OCD). A semi-structured diagnostic interview was administered to patients seeking treatment for OCD in outpatient settings. Structured questions regarding gastrointestinal functioning and IBS symptoms were administered. IBS was diagnosed by a gastroenterologist using Rome I criteria.

Results:

Thirty-seven patients (35.1%) with OCD met criteria for IBS. Of these, 53.8% had IBS with both diarrhea and constipation, 30.8% had diarrhea-predominant IBS, and 15.4% had constipation-predominant IBS.The prevalence rate of IBS in an age- and sex-matched control group (n=40) of medical patients in a family practice was 2.5%. IBS prevalence rates were significantly higher for OCD patients than control subjects (P=.0002).

Conclusion:

IBS and psychiatric illness have high rates of bi-directional comorbidity. This study shows that 35.1% of patients with OCD satisfied criteria for IBS in contrast to 2.5% of the controlled subjects. In most patients the IBS was characterized by both diarrhea and constipation. While taking the initial history clinicians should inquire about bowel symptoms in patients presenting with psychiatric illnesses, including OCD. SSRIs could potentially worsen such symptoms and lead to non-adherence.

Type
Original Research
Information
CNS Spectrums , Volume 11 , Issue 1 , January 2006 , pp. 21 - 25
Copyright
Copyright © Cambridge University Press 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Lynn, RB, Friedman, LS. Irritable bowel syndrome. N Engl J Med. 1993;329:1940–1945.Google Scholar
2.Drossman, DA, McKee, DC, Sandler, RS, et al.Psychosocial factors in the irritable bowel syndrome: A multivariate analysis of patients and nonpatients with irritable bowel syndrome. Gastroenterology. 1988;95:701–708.CrossRefGoogle ScholarPubMed
3.Thompson, WG. C. Functional bowel disorders and D. Functional abdominal pain. In: Drossman, DA, Richter, JE, Talley, NJ, Thompson, WG, Corazziari, E, eds. Functional Gastroinstestinal Disorders: Diagnosis, Pathophysiology and Treatment McLean, VA: Degnon and Associates; 1994:115–173.Google Scholar
4.Talley, NJ, Zinsmeister, AR, Van Dyke, C, Melton, LJ 3rd. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology. 1991;101:927–934.Google Scholar
5.Latimer, PR. Irritable bowel syndrome. Psychosomatics. 1983;24:205–218.CrossRefGoogle ScholarPubMed
6.Sandler, RS, Drossman, DA, Nathan, HP, McKee, DC. Symptom complaints and health care seeking behavior in subjects with bowel dysfunction. Gastroenterology. 1984;87:314–318.Google Scholar
7.Whitehead, WE, Bosmajian, L, Zonderman, AB, Costa, PT Jr, Schuster, MM. Symptoms of psychologic distress associated with irritable bowel syndrome. Comparison of community and medical clinic samples. Gastroenterology. 1988;95:709–714.Google Scholar
8.Kaplan, HI, Freedman, AM, Sadock, BJ. Schizophrenic disorders. In: Comprehensive Textbook of Psychiatry. 3rd ed. Baltimore, Md: Lippincott Williams and Wilkins; 1980:1093–1287.Google Scholar
9.Gupta, S, Masand, P, Kaplan, D, Bhandary, A, Hendricks, S. The relationship between schizophrenia and irritable bowel syndrome (IBS). Schizophr Res. 1997;23:265–268.Google Scholar
10.Masand, P, Kaplan, D, Gupta, S, Bhandary, A, Nasra, G, Margo, K, Kline, M. Major depression and Irritable bowel syndrome (IBS): is there a relationship? J Clin Psychiatry. 1995;56:363–367.Google ScholarPubMed
11.Tollefson, GD, Tollefson, SL, Pederson, M, Luxenberg, M, Dunsmore, G. Comorbid irritable bowel syndrome in patients with generalized anxiety and major depression. Ann Clin Psychiatry. 1991;3:215–222.CrossRefGoogle Scholar
12.Lydiard, RB. Anxiety and the irritable bowel syndrome. Psychiatric Ann. 1992;22:612–618.CrossRefGoogle Scholar
13.Kaplan, D, Masand, P, Gupta, S. The relationship of irritable bowel syndrome (IBS) and panic disorder. Ann Clin Psychiatry. 1996;8:81–88.Google Scholar
14.Noyes, R, Cook, B, Garvey, M, Summers, R. Reduction of gastrointestinal symptoms following treatment for panic disorder. Psychosomatics. 1990;31:75–79.CrossRefGoogle ScholarPubMed
15.Masand, PS, Kaplan, DS, Gupta, S. Irritable bowel syndrome and dysthymia: Is there a relationship? Psychosomatics. 1997;38:63–69.Google Scholar
16.Masand, PS, Kaplan, D, Gupta, S, Bhandary, A. Relationship between irritable bowel syndrome (IBS) and double depression (dysthymia plus major depression). Depression. 1996;3:303–306.Google Scholar
17.Gonzalez-Heydrich, J, Peroutka, SJ. Serotonin receptor and re-uptake sites: pharmacologic significance. J Clin Psychiatry. 1990;51(suppl):5–12.Google Scholar
18.Read, NW, Gwee, KA. The importance of 5-hydroxytryptamine receptors in the gut. Pharmacol Ther. 1994;62:159–173.Google Scholar
19.Longstreth, GF, Drossman, DA. New developments in the diagnosis and treatment of irritable bowel syndrome. Curr Gastroenterol Rep. 2002;4:427–434.Google Scholar
20.Kilkens, TOC, Honig, A, Rozendaal, N, Van Nieuwenhoven, MA, Brummer, RJM. Systematic review: serotonergic modulators in the treatment of irritable syndrome-influence on psychiatric and gastrointestinal symptoms. Aliment Pharmacol Ther. 2003;17:43–51.Google Scholar
21.Masand, PS, Gupta, S, Schwartz, TL, et al.Paroxetine in patients with irritable bowel syndrome (IBS): a pilot open-label study. Prim Care Companion J Clin Psychiatry. 2002;4:12–16.Google Scholar
22.Masand, PS, Gupta, S, Schwartz, TL, et al.Does a preexisting anxiety disorder predict response to Paroxetine in irritable bowel syndrome (IBS)? Psychosomatics. 2002;43:6:451–455.CrossRefGoogle Scholar
23.Ohta, M, Suzuki, T, Ohmori, J, et al.Novel 5-hydroxytryptamine (5-HT3) receptor antagonists. III. Pharmacological evaluations and molecular modeling studies of optically active 4,5,6,7-tetrahydro-1H-benzimidazole derivatives. Chem Pharmacol Bull. 1996;44:1000–1008.Google Scholar
24.Sato, Y, Yamada, M, Yoshida, S, et al.Benzoxazole derivatives as novel 5-HT3 receptor partial agonists in the gut. J Med Chem. 1998;41:3015–3021.Google Scholar
25.Montgomery, SA. Psychopharmacology of obsessive-compulsive disorder. CNS Spectr. 1998;3(suppl 1):33–37.Google Scholar
26.Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.Google Scholar
27.Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. rev. Washington, DC: American Psychiatric Association; 1987.Google Scholar
28.Vidyaranya, VM, Khanna, S, Virk, S, et al. Relationship of irritable bowel syndrome and obsessive compulsive disorder in India. Paper presented at: Annual Meeting of American Psychiatric Association; May 13-18, 2000; Chicago, III.Google Scholar
29.De Ponti, F, Malagelada, JR. Functional gut disorders: the motility to sensitivity disorders. A review of current and investigational drugs for their management. Pharmacol Ther. 1998;80:49–88.Google Scholar
30.Crowell, MD. The role of serotonin in the pathophysiology of irritable bowel syndrome. Am J Manag Care. 2001;7(8 suppl):S252–S260.Google Scholar
31.Lacy, BE, Yu, S. Tegaserod: a new 5HT4 agonist. J Clin Gastroenterol. 2002;34:27–33.Google Scholar
32.Schuster, NM. Diagnostic evaluation of the irritable bowel syndrome. Gastoenterol Clin N Am. 1991;20:269–278.CrossRefGoogle ScholarPubMed